The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists

Published:2024-08 Issue: Volume:351 Page:122796
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Vignoli Alessia,Gori Anna Maria,Berteotti Martina,Cesari Francesca,Giusti Betti,Bertelli Alessia,Kura Ada,Sticchi Elena,Salvadori Emilia,Barbato Carmen,Formelli Benedetta,Pescini Francesca,Marcucci Rossella,Tenori Leonardo,Poggesi Anna

Publisher

Elsevier BV

Reference28 articles.

1. Epidemiology of atrial fibrillation in the 21st century;Kornej;Circ. Res.,2020

2. Which drug should we use for stroke prevention in atrial fibrillation?;Lau;Curr. Opin. Cardiol.,2014

3. Efficacy and safety of direct Oral anticoagulants in patients with atrial fibrillation and high thromboembolic risk;Acanfora;A Systematic Review, Front Pharmacol,2019

4. The pleiotropic effects of antithrombotic drugs in the metabolic–cardiovascular–neurodegenerative disease continuum: impact beyond reduced clotting;Alaaeddine;Clin. Sci.,2021

5. Metabolomics fingerprint predicts risk of death in dilated cardiomyopathy and heart failure;Vignoli;Frontiers in Cardiovascular Medicine,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP